COVID-19 in Patients With Connective Tissue Disease-related Interstitial Lung Disease.
Linh TruongLila PourzandElizabeth R VolkmannPublished in: The Journal of rheumatology (2020)
Infection with the coronavirus disease 2019 (Covid-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), manifests in a myriad of ways ranging from asymptomatic disease to pneumonia and acute respiratory distress syndrome. Advanced age and underlying cardiovascular/pulmonary conditions appear to increase the risk for Covid-19 complications [1,2]. Patients with connective tissue disease-related interstitial lung disease (CTD-ILD) may represent a vulnerable patient population for Covid-19 given their diminished pulmonary reserve. To our knowledge, there are no prospective data reporting outcomes of SARS-CoV-2 infection in patients with CTD-ILD. We herein present all known cases (n = 4) of Covid-19 in CTD-ILD patients at UCLA between January 2020 and August 2020.
Keyphrases
- interstitial lung disease
- coronavirus disease
- respiratory syndrome coronavirus
- sars cov
- systemic sclerosis
- rheumatoid arthritis
- acute respiratory distress syndrome
- idiopathic pulmonary fibrosis
- pulmonary hypertension
- extracorporeal membrane oxygenation
- healthcare
- emergency department
- adipose tissue
- risk factors
- machine learning
- artificial intelligence